These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2054859)

  • 1. Studies on cardiotonic agents. VI. Synthesis of novel 4,5-dihydro-3(2H)-pyridazinone derivatives carrying some benzoheterocycles at the 6-position.
    Nomoto Y; Takai H; Ohno T; Kubo K
    Chem Pharm Bull (Tokyo); 1991 Feb; 39(2):352-7. PubMed ID: 2054859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiotonic agents. 2. Synthesis and structure-activity relationships of 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: a new class of positive inotropic agents.
    Sircar I; Duell BL; Bobowski G; Bristol JA; Evans DB
    J Med Chem; 1985 Oct; 28(10):1405-13. PubMed ID: 2864447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydropyridazinone cardiotonics: the discovery and inotropic activity of 1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-2H -indol-2- one.
    Robertson DW; Krushinski JH; Beedle EE; Wyss V; Pollock GD; Wilson H; Kauffman RF; Hayes JS
    J Med Chem; 1986 Oct; 29(10):1832-40. PubMed ID: 3761304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for the treatment of congestive heart failure.
    Sircar I; Steffen RP; Bobowski G; Burke SE; Newton RS; Weishaar RE; Bristol JA; Evans DB
    J Med Chem; 1989 Feb; 32(2):342-50. PubMed ID: 2536438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and structure-activity relationship studies of 6-phenyl-4,5-dihydro-3(2H)-pyridazinone derivatives as cardiotonic agents.
    Wang T; Dong Y; Wang LC; Xiang BR; Chen Z; Qu LB
    Arzneimittelforschung; 2008; 58(11):569-73. PubMed ID: 19137907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiotonic agents. 4. Synthesis and biological evaluation of N-substituted 2,4,4a,5-tetrahydro-3H-indeno[1,2-c]pyridazin-3-ones: rigid structures derived from CI-930 and analogues.
    Sircar I; Duell BL; Cain MH; Burke SE; Bristol JA
    J Med Chem; 1986 Nov; 29(11):2142-8. PubMed ID: 3783575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiotonic agents. 3. Synthesis and biological activity of novel 6-(substituted 1H-imidazol-4(5)-yl)-3(2H)-pyridazinones.
    Sircar I; Bobowski G; Bristol JA; Weishaar RE; Evans DB
    J Med Chem; 1986 Feb; 29(2):261-7. PubMed ID: 3950907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imidazole-pyridine bioisosterism: comparison of the inotropic activities of pyridine- and imidazole-substituted 6-phenyldihydropyridazinone cardiotonics.
    Robertson DW; Krushinski JH; Pollock GD; Hayes JS
    J Med Chem; 1988 Feb; 31(2):461-5. PubMed ID: 3339616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiotonic agents. 6. Synthesis and inotropic activity of 2,4-dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-3H-pyrazol-3-ones: ring-contracted analogues of imazodan (CI-914).
    Sircar I; Morrison GC; Burke SE; Skeean R; Weishaar RE
    J Med Chem; 1987 Oct; 30(10):1724-8. PubMed ID: 3656349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of NSP-804 and NSP-805, novel cardiotonic agents with vasodilator properties.
    Mochizuki N; Uchida S; Miyata H
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):983-95. PubMed ID: 7687727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on cardiotonic agents. VII. Potent cardiotonic agent KF15232 with myofibrillar Ca2+ sensitizing effect.
    Nomoto Y; Takai H; Ohno T; Kubo K
    Chem Pharm Bull (Tokyo); 1991 Apr; 39(4):900-10. PubMed ID: 1893496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of cardiotonic agents. 8. Synthesis and biological activities of optically active 6-(4-(benzylamino)-7-quinazolinyl)-4,5-dihydro-5-methyl-3(2H)- pyridazinone (KF15232).
    Nomoto Y; Takai H; Ohno T; Nagashima K; Yao K; Yamada K; Kubo K; Ichimura M; Mihara A; Kase H
    J Med Chem; 1996 Jan; 39(1):297-303. PubMed ID: 8568820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiotonic agents. 5. 1,2-Dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-6-methyl-2-oxo-3- pyridinecarbonitriles and related compounds. Synthesis and inotropic activity.
    Sircar I; Duell BL; Bristol JA; Weishaar RE; Evans DB
    J Med Chem; 1987 Jun; 30(6):1023-9. PubMed ID: 3585900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiotonic agents. 7. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from guinea pig cardiac muscle by 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds. Structure-activity relationships and correlation with in vivo positive inotropic activity.
    Sircar I; Weishaar RE; Kobylarz D; Moos WH; Bristol JA
    J Med Chem; 1987 Nov; 30(11):1955-62. PubMed ID: 2822926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and cardiotonic activity of novel biimidazoles.
    Matthews DP; McCarthy JR; Whitten JP; Kastner PR; Barney CL; Marshall FN; Ertel MA; Burkhard T; Shea PJ; Kariya T
    J Med Chem; 1990 Jan; 33(1):317-27. PubMed ID: 2153209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on cardiotonic agents. V. Synthesis of 1-(6,7-dimethoxy-4-quinazolinyl)piperidine derivatives carrying various 5-membered heterocyclic rings at the 4-position.
    Nomoto Y; Takai H; Hirata T; Teranishi M; Ohno T; Kubo K
    Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):86-90. PubMed ID: 2049812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and bioactivity of 6-phenyl-4,5-dihydro-3(2H)-pyridazinone derivatives.
    Wang T; Dong Y; Wang LC; Chen Z
    Arzneimittelforschung; 2007; 57(10):641-6. PubMed ID: 18074757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on cardiotonic agents. III. Synthesis of 1-[1-(6,7-dimethoxy-4-quinazolinyl)-4-piperidinyl]-3-substituted 2-imidazolidinone and 2-imidazolidinethione derivatives.
    Nomoto Y; Obase H; Takai H; Hirata T; Teranishi M; Nakamura J; Ohno T; Kubo K
    Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2467-71. PubMed ID: 2285977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-Aroyl-1,3-dihydro-2H-imidazol-2-ones: a new class of cardiotonic agents. 2. Effect of 4-pyridoyl substituents and related compounds.
    Schnettler RA; Dage RC; Palopoli FP
    J Med Chem; 1986 May; 29(5):860-2. PubMed ID: 3701794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imidazo[1,2-a]pyridines. I. Synthesis and inotropic activity of new 5-imidazo[1,2-a]pyridinyl-2(1H)-pyridinone derivatives.
    Yamanaka M; Miyake K; Suda S; Ohhara H; Ogawa T
    Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1556-67. PubMed ID: 1934178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.